Brief: Viva Biotech Secures Approximately US $210 Million Funding
20/11/2023 12:32
Nov 20 (Reuters) - VIVA Biotech Holdings 1873.HK :
* VIVA BIOTECH SECURES APPROXIMATELY US $210 MILLION FUNDING
* VIVA BIOTECH - COMPLETED FUNDING ROUND, SECURING ABOUT
US$210
MILLION,BRINGING IN STRATEGIC INVESTORS, TEMASEK, HIGHLIGHT
CAPITAL (HLC) AND TRUE LIGHT
Source text for Eikon: ID:nPn1Tr81za
Further company coverage: 1873.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VIVA Biotech Holdings
See all newsVIVA Biotech H1 profit falls on weaker investment income, FX headwinds
Brief: Viva Biotech Posts FY Net Profit RMB269.3 Million
Brief: Viva Biotech Received Declaration Letter
Brief: Viva Biotech Says Hangzhou Viva Zongchen Agreed To Invest RMB25.0 Million To Fund
Brief: Viva Biotech Passing Of U.S. FDA On-Site Inspection By Langhua Pharmaceutical